Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients

NCT06593197 · clinicaltrials.gov ↗
PHASE4
Phase
ENROLLING_BY_INVITATION
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dow University of Health Sciences